Filter
Top Products
5
PHASER 8860 / 8860MFP EVALUATOR GUIDE
EVALUATE COSTS
When evaluating the costs of printing, it’s important to first think about your current actual printing
costs, whether you are using black and white or colour printers. Once you understand the actual
per-page costs of your printing activities, you can gain a deeper understanding of the total costs
associated with your printer over its lifetime.
PER-PAGE PRINTING COSTS
When evaluating printing costs, most small and medium-sized companies think about the costs
of purchasing new consumables for their printer. Another way to think about printing costs is
the actual per-page cost of the pages you print, as this offers the truest reflection of the cost of
your printing activity. According to gap intelligence, inc.
1
, the average per page printing costs for
workgroup-class colour printers are 1.2 € cents for black and white pages, and
6 € cents for colour pages. The costs fluctuate depending on the area coverage
of the print, or the amount of toner or solid ink used to print the image.
With the Phaser 8860 printer and Phaser 8860MFP, Xerox is offering a
revolutionary solution for controlling colour printing costs. With these products,
the cost of printing colour pages is the same as the cost of printing black and
white pages. The chart below illustrates the area coverage rates for a variety of
commonly printed business documents, and compares the costs of printing them
on average colour laser printers against the Phaser 8860 and Phaser 8860MFP.
Take a look, and consider how much your company can save while deploying
colour capabilities into your environment.
HOW THE PHASER 8860/PHASER 8860MFP EXCEED THE PRINTING COSTS REQUIREMENT
1
gap intelligence – July 30, 2007
Letter Presentation Conference Agenda Newsletter
B/W
Coverage 3% 7% 11% 25%
Average Laser
2
c 0.0130 c0.0239 c0.0340 c0.0720
8860 / 8860MFP
E 0.0100 E0.0220 E0.0340 E0.0760
Color
Total Coverage 4% 10% 18% 45%
Average Laser
2
c0.0239 c0.0480 c0.0942 c0.2320
8860 / 8860MFP
E0.0073 E0.0190 E0.0250 E0.0580
1
gap intelligence – July 30, 2007
2
Costs are approximate. Actual costs will vary depending on vendor and product model.
Same Low Price
Quarterly Review
Fund’s Quarterly profi ts expected to rise.
Decreased sold debt and increased revenue from
international holdings have propelled this quarter’s
earnings into the upper 25 percentile.
43%
125. 68
(155.02)
(45.90)
205.21
(33.76)
125. 68
(26.02)
560.23
25.21
343.76
825.68
125. 68
155. 02
45.90
205.21
(237.76)
225.45
(195.12)
125. 68
(41.85)
135. 41
154.7 6
(45.20)
Industry changes yield selling opportunities. The fund
seeks capital appreciation by investing in promising biotechnology
companies throughout the world. Company selection comprises
primarily “red” (medical processes, especially antibiotics production)
and “green” (agricultural processes, including transgenic plant cre-
ation) biotechnology corporations. Under normal circumstances, the
fund will invest substantially all (and in any event, not less than 75%)
of its net assets (plus any borrowings for investment purposes) in
equity securities. All companies must meet Prometheus’ extensive .
Quarterly Review
Fund’s Quarterly profi ts expected to rise.
Decreased sold debt and increased revenue from
international holdings have propelled this quarter’s
earnings into the upper 25 percentile.
43%
125. 68
(155.02)
(45.90)
205.21
(33.76)
(125.68)
125. 68
(26.02)
560.23
25.21
343.76
825.68
125. 68
155. 02
45.90
205.21
(237.76)
225.45
(195.12)
125. 68
(41.85)
135. 41
154.7 6
(45.20)
Industry changes yield selling opportunities. The fund
seeks capital appreciation by investing in promising biotechnology
companies throughout the world. Company selection comprises
primarily “red” (medical processes, especially antibiotics production)
and “green” (agricultural processes, including transgenic plant cre-
ation) biotechnology corporations. Under normal circumstances, the
fund will invest substantially all (and in any event, not less than 75%)
of its net assets (plus any borrowings for investment purposes) in
equity securities. All companies must meet Prometheus’ extensive .
colourb/w